Although healthcare M&A activity in Q3 declined slightly from the previous quarter, analysts believe the activity level declined much less than expected given the numerous headwinds—inflation, rising interest rates, labor shortages, and a poor stock market among them. These adverse forces were likely counterbalanced, in part, by the waning availability of federal funding for COVID-19 relief, which caused healthcare providers to seek out capital through other means. Overall, then, deal volume remained strong across all sectors.
Read the full article: Healthcare Transactions Q3 2022 //
Source: https://www.bassberry.com/news/healthcare-transactions-q3-2022